This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.
| less than a minute read

Implantable LEDs have potential to destroy cancer cells

Get in touch

Avatar
Derek Silva
Vice President, Marketing

Get in touch

Avatar
Derek Silva
Vice President, Marketing

Researchers at the University of Notre Dame recently published a study demonstrating how implanted LEDs, when activated, could trigger a response by the immune system that would cause cancer cells to self-destruct. 

The treatment is still a ways off as additional laboratory and clinical testing will be required, but this use of implanted LEDs could be a solution for cancerous tissue deep inside the body that is otherwise difficult to reach with other forms of treatment. 

It's exciting to see research laboratories bringing different disciplines together – in this case optical engineering with medical expertise – to help solve some of the world's toughest challenges.

 

The results from these studies suggest a future path towards a wireless, implanted LED-based device capable of triggering photodynamic immunogenic cell death in deep-seated cancerous tissue. The approach could pave the way for new cancer treatments that are currently difficult to reach and treat effectively.
www.techtimes.com/...
featured image

Tags

innovation, medical device, leds, cancer research, english, highlight

Get in touch

Avatar
Derek Silva
Vice President, Marketing

Get in touch

Avatar
Derek Silva
Vice President, Marketing

Latest Insights

Creating, sharing and inspiring change. For good.

The global issues we face are challenging and interconnected. They can seem insurmountable. But if you know where to look, co-operation, positive change and hope are all around us. Build Beyond Ever Better is a project that recognises the progress being made, and the amazing people who are making a difference. Share your own hopes, pledges and projects with #BBEB, or become a contributor.

Please read our BBEB Charter PDF.